Brain glucose metabolism in Rett syndrome

Pediatric Neurology

Volumn 27, Issue 2, 2002, Pages 117-122

  Villemagne, Patricia M ^a   Naidu, Sakkubai ^a   Villemagne, Victor L ^a   Yaster, Myron ^a   Wagner Jr, Henry N ^a   Harris, James C ^a   Moser, Hugo W ^a   Johnston, Michael V ^a   Dannals, Robert F ^a   Wong, Dean F ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY; DISEASE COURSE; DOWN SYNDROME; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MENTAL DEFICIENCY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RETT SYNDROME;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; HUMANS; MALE; PARIETAL LOBE; RADIOPHARMACEUTICALS; RETT SYNDROME; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036696126     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00399-5     Document Type: Article

References (63)

1. Rett A. Uber ein eiggenatiges hirnatrophisches syndrome bei hyperammonamie in kindersalter. Wien Ned Wochenschr. 116:1966;723-736
2. Schanen N.C. Molecular approaches to the Rett syndrome gene. J Child Neurol. 14:1999;806-814
3. Olsson B., Rett A. Autism and Rett syndrome: Behavioural investigations and differential diagnosis. Dev Med Child Neurol. 29:1987;429-441
4. Sirianni N., Naidu S., Pereira J., Pillotto R.F., Hoffman E.P. Rett syndrome: Confirmation of X-linked dominant inheritance, and localization on the gene to Xq28. Am J Hum Genet. 63:1998;1552-1558
5. Percy A.K. Genetics of Rett syndrome: Properties of the newly discovered gene and pathobiology of the disorder. Curr Opin Pediatr. 12:2000;589-595
6. Couvert P., Bienvenu T., et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 10:2001;941-946
7. Armstrong D.D. The neuropathology of Rett syndrome - overview 1994. Neuropediatrics. 26:1995;100-104
8. Naidu S. Rett Syndrome: A disorder affecting early brain growth. Ann Neurol. 42:1997;3-10
9. Bauman M.L., Kemper T.K., Arin D.M. Microscopic observations of the brain in Rett syndrome. Neuropediatrics. 26:1995;105-108
10. Armstrong D.D., Dunn K., Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol. 57:1998;1013-1017
11. Kaufman W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex. 10:2000;981-991
12. Naidu S., Murphy M., Moser H.W., Rett A. Rett syndrome-natural history in 70 cases. Am J Med Genet. 1:1986;61-72
13. Nihei K., Naitoh H. Cranial computed tomographic and magnetic resonance imaging studies on the Rett syndrome. Brain Dev. 12:1990;101-105
14. Reiss A.L., Faruque F., Naidu S., et al. Neuroanatomy of Rett syndrome: A volumetric imaging study. Ann Neurol. 34:1993;227-234
15. Subramanian B., Naidu S., Reiss A.L. Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology. 48:1997;399-407
16. Harris J.C., Wong D.F., Wagner H.N. Jr, et al. Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome. Am J Med Genet Suppl. 1:1986;201-210
17. Wong D.F., Harris J.C., Naidu S., et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA. 93:1996;5539-5543
18. Yamashita Y., Matsuishi T., Ishibashi M., et al. Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neurol Sci. 154:1998;146-150
19. Blue M.E., Naidu S., Johnston M.V. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol. 156:1999;345-352
20. Blue M.E., Naidu S., Johnston M.V. Development of aminoacid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol. 45:1999;541-545
21. Wenk G.L., Naidu S., Casanova M.F., Kitt C.A., Moser H. Altered neurochemical markers in Rett syndrome. Neurology. 41:1991;1753-1756
22. Yoshikawa H., Fueki N., Suzuki H., Sakuragawa N., Lio M. Cerebral blood flow and oxygen metabolism in the Rett syndrome. Brain Dev. 14:Suppl 1992;S69-74
23. Nielsen J.B., Friberg L., Lou H., Lassen N.A., Sam I.L. Immature pattern of brain activity in Rett syndrome. Arch Neurol. 47:1990;982-986
24. Burroni L., Aucone A.M., Volerrani D., et al. Brain perfusion abnormalities in Rett syndrome: A qualitative SPET study with 99Tc(m)-ECD. Nuclear Med Commun. 18:1997;527-534
25. Lappalainen R., Liewendahl K., Sainio K., Nikkinen P., Riikonen R.S. Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand. 95:1997;44-50
26. Bjure J., Uvebrant P., Vestergren E., Hagberg B. Regional cerebral blood flow abnormalities in Rett syndrome. Eur Child Adolesc Psychiatry. 6:Suppl 1 1997;64-66
27. 18FDG positron emission tomography. Science. 231:1986;840-843
28. Chugani H.T., Phelps M.E., Mazziota J.C. Positron emission tomography study of human brain functional development. Ann Neurol. 22:1987;487-497
29. Chugani H.T., Chugani D.C. Basic mechanisms of childhood epilepsies: Studies with positron emission tomography. Adv Neurol. 79:1999;883-891
30. Juhasz C., Nagy F., Watson C., et al. Glucose and [11C] flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology. 53:1999;2037-2045
31. Shapiro M.B. Decline in cerebral glucose utilization and cognitive function with aging in Down's syndrome. J Neurol Neurosurg Psychiatry. 50:1987;766-774
32. Schifter T., Hoffman J.M., Hatten Jr H.P., Hanson M.W., Coleman R.E., DeLong G.R. Neuroimaging in infantile autism. J Child Neurol. 9:1999;155-161
33. Eidelberg D., Moeller J.R., Antonini A., Kazumata K., Dhawan V., Budman C., Feigin A. The metabolic anatomy of Tourette's syndrome. Neurology. 48:1997;927-934
34. The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol. 23:1988;425-428
35. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of non-carrier added 2-[18F]-fluoro-2-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic susbtitution. J Nuc Med. 27:1986;235-238
36. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurements of local cerebral glucose metabolic rate in humans with (F-18) 2-Fluoro-2-Deoxy-D-glucose validation of method. Ann Neurol. 6:1979;371-388
37. Duara R., Grady C., Haxby J., et al. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887
38. Gur R.E., Resnick S.M., Alavi A., et al. Regional brain function in schizophrenia. Arch Gen Psychyatry. 44:1987;119-125
39. Friedland R.F., Budinger T.F., Koss E., Ober B.A. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett. 53:1985;235-240
40. Hibbard L.S., McGlone J.S., Davis D.W., Hawkins R.A. Three-dimensional representation and analysis of brain energy metabolism. Science. 236:1987;1641-1646
41. Theodore W.H., Di Chiro G., Margolin R., Fishbein D., Porter R.J., Brooks R.A. Barbiturates reduce human cerebral glucose metabolism. Neurology. 36:1986;60-64
42. Magistretti P.J. Cellular bases of functional brain imaging: Insights from neuron-glia metabolic coupling. Brain Res. 886:2000;108-112
43. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science. 283:1999;496-497
44. Niedermeyer E., Naidu S.B., Plate C. Unusual theta rhythm over central region in Rett syndrome: Considerations of the underlying dysfunction. Clin Electroencephalogr. 28:1997;36-43
45. Chugani H.T. Positron emission tomography in mitochondrial diseases. Biofactors. 7:1998;255-257
46. Nariai T., Ohno K., Akimoto H., et al. Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome - xenon CT and PET study. Keio J Med. 49:Suppl 1 2000;A68-70
47. Sano M.I., Mosome Y., Uchigata M., Senda M. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand. 92:1995;497-502
48. Frackowiack R.S., Herold S., Petty R.K., Morgan-Hughes J.A. The cerebral metabolism of glucose and oxygen measured with positron emission tomography in patients with mitochondrial diseases. Brain. 111:1988;1009-1024
49. Glaze G.G., Frost J.D., Zoghbi H.Y., Percy A.K. Rett's syndrome: Correlation of electroencephalographic characteristics with clinical staging. Arch Neurol. 44:1987;1053-1056
50. Molnar M.J., Valikovics A., Molnar S., et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology. 55:2000;544-548
51. Cornford M.E., Philippart M., Jacobs B., Scheibel A.B., Vinters H.V. Neuropathology of Rett syndrome: Case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol. 9:1994;424-431
52. Cardaioli E., Dotti M.T., Hayek G., Zappella M., Federico A. Studies on mitochondrial pathogenesis of Rett Syndrome: Ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835. J Submicrosc Cytol Pathol. 31:1999;301-304
53. Haas R.H., Light M., Rice M., Barshop B.A. Oxidative metabolism in Rett syndrome: 1. Clinical studies. Neuropediatrics. 26:1995;90-94
54. Matsuishi T., Urabe F., Percy A.K., et al. Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J Child Neurol. 9:1994;26-30
55. Heh C., Smith R., Wu J., et al. Positron emission tomography of the cerebellum in autism. Am J Psychiatry. 146:1989;242-245
56. Murakami J.W., Courchesne E., Haas R.H., Press G.A., Yeung-Courchesne R. Cerebellar and cerebral abnormalities in Rett syndrome. Am J Roentgenol. 159:1992;177-183
57. Oldfors A., Sourander P., Armstrong D.L., Percy A.K., Witt-Engerstrom I., Hagberg B.A. Rett syndrome: Cerebellar pathology. Pediatric Neurol. 6:1990;310-314
58. Duara R., Grady C., Haxby J., et al. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887
59. Hoffman J.M., Welsh-Bohner K.A., Hanson M., et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 41:2000;1920-1928
60. Schapiro M.B., Grady C.L., Kumar A., et al. Regional cerebral glucose metabolism is normal in young adults with Down syndrome. J Cereb Blood Flow Metab. 10:1990;199-206
61. Rumsey J.M., Duara R., Grady C., et al. Brain metabolism in autism: Resting cerebral glucose utilization rates as measured with positron emission tomography. Arch Gen Psychiatry. 42:1985;448-455
62. Horwitz B., Rumsey J.H., Grady C.L., Rapoport S.I. The cerebral metabolic landscape in autism: Intercorrelation of regional glucose utilization. Arch Neurol. 45:1988;749-755
63. Rumsey J.M., Ernst M. Functional neuroimaging of autistic disorders. Ment Retard Dev Disabil Res Rev. 6:2000;171-179